Advanced search
Publication Cover
Acta Cardiologica Volume 59, 2004 - Issue 6
Submit an article Journal homepage
4
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Factor V Leiden is a risk factor for myocardial infarction in young Turkish men

Gultekin F. HobikogluDepartment of Cardiology, Siyami Ersek Thoracic and Cardiovascular Surgery Center, Istanbul, TurkeyCorrespondence[email protected]
,
Umit AkyuzDepartment of Internal Medicine, Haydarpasa Numune Hospital, Istanbul, Turkey
,
Filiz AkyuzDepartment of Internal Medicine, Haydarpasa Numune Hospital, Istanbul, Turkey
,
Orhan OzerDepartment of Cardiology, Siyami Ersek Thoracic and Cardiovascular Surgery Center, Istanbul, Turkey
,
Dilvin GÜCneyDETAM, University of Istanbul, Istanbul, Turkey
,
Ahmet NarinDepartment of Cardiology, Siyami Ersek Thoracic and Cardiovascular Surgery Center, Istanbul, Turkey
&
Nihan UnaltunaDETAM, University of Istanbul, Istanbul, Turkey
 show all
Pages 594-597 | Received 17 Dec 2003, Accepted 21 Jun 2004, Published online: 23 May 2017

References

  • Bertina RM, Koeleman RPC, Koster T, Rosendaal FR, Dir-ven RJ, Ronde H de, Van der Velden PA, Reitsma PH. Muta-tion in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64–8.
  • Greengard JS, Sun X, Xu X, Fernandez GA, Griffin JH, Evatt B. Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet 1994; 343: 1362–7.
  • Zöller B, Dahlback B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 1994; 343: 1536–40.
  • Voorberg J, Roelse J, Koopman B, Buller H, Berends F, Cate JW, Mertens K, van Mourik JA. Association of idio-pathic thromboembolism with single point mutation at Arg506 of factor V. Lancet 1994; 343: 1535–9.
  • Dahlback B, Carlsson M, Svensson PJ. Familial throm-bophilia due to a previously unrecognized mechanism char-acterized by poor anticoagulant response to activated pro-tein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004–9.
  • Lindblad B, Svensson PJ, Dahlback B. Arterial and venous thromboembolism with fatal outcome and resistance to acti-vated protein C. Lancet 1994; 343: 917–21.
  • Holm J, Zöller B, Svensson PJ, Berntorp E, Erhardt L, Dahlback B. Myocardial infarction associated with homozy-gous resistance to activated protein C. Lancet 1994; 344: 952–7.
  • Marz W, Seydewitz H, Winkelmann B, Chen M, Nauck M, Witt I. Mutation in coagulation factor V associated with resistance to activated protein C in patients with coronary artery disease. Lancet 1995; 345: 526–30.
  • Kontula K, Ylikorkala A, Miettinen H, Vuorio A, Kauppinen-Makelin R, Hamalainen L, Palomaki H, Kaste M. Arg506Gln Factor V mutation (Factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocar-dial infarction. Thromb Haemost 1995; 73: 558–62.
  • Ridker PM, Hennekens CH, Lindpainter K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332: 912–6.
  • Emmerich J, Poirier 0, Evans A, Marques-Vidal P, Arveiler D, Luc G, Aiach M, Cambien F. Myocardial infarc-tion, Arg506 to Gin factor V mutation, and activated pro-tein C resistance. Lancet 1995; 345: 321–5.
  • Van Bockxmeer FM, Baker RI, Taylor RR. Premature ischaemic heart disease and the gene for coagulation fac-tor V. Nat Med 1995; 1: 185–9.
  • Ardissino D, Peyvandi F, Merlini PA, Colombi E, Man-nucci PM. Factor V (Arg506 ->G1n) mutation in young sur-vivors of myocardial infarction. Thromb Haemost 1996; 75: 701–6.
  • World Health Organization. Ischemic heart disease registers: report of the Fifth Work Group, including a second revi-sion of the operating protocol, Copenhagen, Denmark, April 26–29, 1971. Copenhagen, Denmark: World Health Organi-zation, Regional Office for Europe, 1971.
  • Millar SA, Dijkes DD, Polesky HF. A simple salting out procedure for extracting DNA from nucleated cells. Nucleic Acids Res 1988; 16: 1215–9.
  • Mizuno K, Satomura K, Miyamoto A, Arakawa K, Shibuya T, Arai T, Kurita A, Nakamura H, Ambrose JA. Angioscopic evaluation of coronary artery thrombi in acute coranary syndromes. N Engl J Med 1992; 326: 287–91.
  • DiSciascio G, Cowley MJ, Goudreau E, Vetrovec GW, John-son DE. Histopathologic correlates of unstable ischemic syn-dromes in patients undergoing directional coronary atherec-tomy: in vivo evidence of thrombosis, ulceration and inflammation. Am Heart J 1994; 128: 419–26.
  • Koster T, Rosendaal FR, Ronde H de, Briet E, Vanden-broucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503–8.
  • Svensson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517–22.
  • Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factorV Leiden (activated protein C resistance). Blood 1995; 85: 1504–10.
  • Rosendaal FR, Bertina RM, Reitsma PH. Evaluation of activated protein C resistance in stored plasma. Lancet 1994; 343: 1289–95.
  • Takamiya 0, Ishida F, Kodaira H. APC resistance and MnlI genotype (Gln 506) of coagulation factor V are rare in the Japanese population. Thromb Haemost 1995; 74: 996–9.
  • Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133–4.
  • Gurgey A, Mesci L. Prevalence of factor V Leiden (1691 G A mutation in Turkey. Turk J Pediatr 1997; 39(3): 313–5.
  • Van de Water NS, French JK, Lund M, Hyde TA, White HD, Browett PJ. Prevalence of factor V Leiden and prothrombin variant G20210A in patients aged . J Am Coll Cardiol 2000; 36(3): 717–22.
  • Mansourati J, Da Costa A, Munier S, Mercier B, Tardy B, Ferec C, Isaaz K, Blanc JJ. Prevalence of factor V Leiden in patients with myocardial infarction and normal coronary angiography. Thromb Haemost 2000; 83(6): 822–5.
  • Marz W, Seydewitz H, Winkelmann B, Chen M, Nauck M, Witt I. Mutation in coagulation factor V associated with resistance to activated protein C in patients with coronary artery disease. Lancet 1995; 345: 526.
  • Rosendaal FR, Siscovick DS, Schwartz SM, Beverly RK, Psaty BM, Longstreth Jr WT, Raghunathan TE, Koepsell TD, Reitsma PH. Factor V Leiden (resistance to activated Protein C) increases the risk of myocardial infarc-tion in young women. Blood 1997; 89(8): 2817–21.
  • Ridker PM, Hennekens CH, Lindpainter K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332: 912–6.
  • Emmerich J, Poirier 0, Evans A, Marques-Vidal P. Arveiler D, Luc G, Aiach M, Cambien F. Myocardial infarc-tion, Arg506 to Gln factor V mutation, and activated pro-tein C resistance. Lancet 1995; 345: 321.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novo Nordisk – Driving change to defeat serious chronic diseases.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.